Procalcitonin is a specific marker for detecting bacterial infection in patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 39, Issue 8, 2012, Pages 1517-1523

  Sato, Hiroe ^a   Tanabe, Naohito ^b   Murasawa, Akira ^a   Otaki, Yasuhiro ^a   Sakai, Takehito ^a   Sugaya, Toshiaki ^a   Ito, Satoshi ^a   Otani, Hiroshi ^a   Abe, Asami ^a   Ishikawa, Hajime ^a   Nakazono, Kiyoshi ^a   Kuroda, Takeshi ^c   Nakano, Masaaki ^d   Narita, Ichiei ^c  

^a Niigata Rheumatic Center   (Japan)

^b UNIVERSITY OF NIIGATA PREFECTURE   (Japan)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

Author keywords

Bacterial infection; C reactive protein; Procalcitonin; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE EXACERBATION; ERYTHROCYTE SEDIMENTATION RATE; FALSE POSITIVE RESULT; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY;

EID: 84864547912     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.111601     Document Type: Article

References (34)

1. Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet 2007;370:1861-74. (Pubitemid 350180008)
2. Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-75.
3. Oberhoffer M, Karzai W, Meier-Hellmann A, Reinhart K. Procalcitonin. A new diagnostic parameter for severe infections and sepsis. Anaesthesist 1998;47:581-7. (Pubitemid 28374954)
4. Becker KL, Nylen ES, White JC, Muller B, Snider RH Jr. Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: A journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004;89:1512-25. (Pubitemid 38507896)
5. Linscheid P, Seboek D, Nylen ES, Langer I, Schlatter M, Becker KL, et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 2003;144:5578-84. (Pubitemid 37476087)
6. Hugle T, Schuetz P, Mueller B, Laifer G, Tyndall A, Regenass S, et al. Serum procalcitonin for discrimination between septic and non-septic arthritis. Clin Exp Rheumatol 2008;26:453-6. (Pubitemid 352003215)
7. Kuuliala A, Takala A, Siitonen S, Leirisalo-Repo M, Repo H. Cellular and humoral markers of systemic inflammation in acute reactive arthritis and early rheumatoid arthritis. Scand J Rheumatol 2004;33:13-8. (Pubitemid 38328077)
8. Martinot M, Sordet C, Soubrier M, Puechal X, Saraux A, Liote F, et al. Diagnostic value of serum and synovial procalcitonin in acute arthritis: A prospective study of 42 patients. Clin Exp Rheumatol 2005;23:303-10. (Pubitemid 40823537)
9. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
10. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc 1949;140:659-62.
11. Aikawa N, Fujishima S, Endo S, Sekine I, Kogawa K, Yamamoto Y, et al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 2005;11:152-9. (Pubitemid 40933683)
12. Nylen ES, Whang KT, Snider RH Jr, Steinwald PM, White JC, Becker KL. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998;26:1001-6. (Pubitemid 28272848)
13. Delevaux I, Andre M, Colombier M, Albuisson E, Meylheuc F, Beque RJ, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 2003;62:337-40. (Pubitemid 36363440)
14. Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997;40:1250-6. (Pubitemid 27430136)
15. Moosig F, Csernok E, Reinhold-Keller E, Schmitt W, Gross WL. Elevated procalcitonin levels in active Wegener's granulomatosis. J Rheumatol 1998;25:1531-3. (Pubitemid 28364758)
16. Morath C, Sis J, Haensch GM, Zeier M, Andrassy K, Schwenger V. Procalcitonin as marker of infection in patients with Goodpasture's syndrome is misleading. Nephrol Dial Transplant 2007;22:2701-4. (Pubitemid 47365537)
17. Quintana G, Medina YF, Rojas C, Fernandez A, Restrepo JF, Rondon F, et al. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus. J Clin Rheumatol 2008;14:138-42.
18. Scire CA, Cavagna L, Perotti C, Bruschi E, Caporali R, Montecucco C. Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. Clin Exp Rheumatol 2006;24:123-8. (Pubitemid 43826859)
19. Tamaki K, Kogata Y, Sugiyama D, Nakazawa T, Hatachi S, Kageyama G, et al. Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases. J Rheumatol 2008;35:114-9.
20. Zycinska K, Wardyn KA, Zielonka TM, Tyszko P, Straburzynski M. Procalcitonin as an indicator of systemic response to infection in active pulmonary Wegener's granulomacytosis. J Physiol Pharmacol 2008;59 Suppl 6:839-44.
21. Buhaescu I, Yood RA, Izzedine H. Serum procalcitonin in systemic autoimmune diseases - where are we now? Semin Arthritis Rheum 2010;40:176-83.
22. Chen DY, Lan JL, Lin FJ, Hsieh TY. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J Rheumatol 2004;31:2189-98.
23. Kadar J, Petrovicz E. Adult-onset Still's disease. Best Pract Res Clin Rheumatol 2004;18:663-76. (Pubitemid 39549818)
24. Lamprecht P, Kumanovics G, Mueller A, Csernok E, Komocsi A, Trabandt A, et al. Elevated monocytic IL-12 and TNF-alpha production in Wegener's granulomatosis is normalized by cyclophosphamide and corticosteroid therapy. Clin Exp Immunol 2002;128:181-6. (Pubitemid 34451197)
25. Ito Y, Fukatsu A, Baba M, Mizuno M, Ichida S, Sado Y, et al. Pathogenic significance of interleukin-6 in a patient with antiglomerular basement membrane antibody-induced glomerulonephritis with multinucleated giant cells. Am J Kidney Dis 1995;26:72-9.
26. Rau M, Schiller M, Krienke S, Heyder P, Lorenz H, Blank N. Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis. J Rheumatol 2010;37:2369-76.
27. Takeuchi T, Miyasaka N, Tatsuki Y, Yano T, Yoshinari T, Abe T, et al. Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis. Ann Rheum Dis 2011;70:1208-15.
28. Knudsen LS, Hetland ML, Johansen JS, Skjodt H, Peters ND, Colic A, et al. Changes in plasma IL-6, plasma VEGF and serum YKL-40 during treatment with etanercept and methotrexate or etanercept alone in patients with active rheumatoid arthritis despite methotrexate therapy. Biomark Insights 2009;4:91-5.
29. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial. Lancet 2004;363:600-7. (Pubitemid 38264177)
30. Rothenburger M, Markewitz A, Lenz T, Kaulbach HG, Marohl K, Kuhlmann WD, et al. Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein. Clin Chem Lab Med 1999;37:275-9. (Pubitemid 29209741)
31. Ammori BJ, Becker KL, Kite P, Nylen ES, White JC, Barclay GR, et al. Calcitonin precursors: Early markers of gut barrier dysfunction in patients with acute pancreatitis. Pancreas 2003;27:239-43. (Pubitemid 37205871)
32. Sato H, Sakai T, Sugaya T, Otaki Y, Aoki K, Ishii K, et al. Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis. Clin Rheumatol 2009;28:1113-6.
33. Desideri-Vaillant C, Rouby Y, Cardon N, Vinsonneau U, Laborde JP. Analytical interference in determination of procalcitonin by PCT-Q (Brahms). Pathol Biol 2006;54:293-5.
34. Desvignes P, Boutib A. Semiquantitative determination of blood procalcitonin by the immunochromatographic BRAHMS PCT-Q test: False positive result. Ann Biol Clin 2005;63:358-9.